Home | Articles
Published on:August 2016
Indian Journal of Pharmaceutical Education and Research, 2016; 50(3):391-396
Original Article | doi:10.5530/ijper.50.3.11

Evaluation of Anti-obesity Effect of Fattolin, a Polyherbal Formulation in Progesterone Induced Obesity in Mice


Authors and affiliation (s):

Dilpesh Jain1, Preeti Bavage1, Akansha Sable1, Mitali Gokhale1

1Department of Pharmacology, Sinhgad College of Pharmacy, Pune-411041, INDIA.

Abstract:

Progesterone imbalance modulates lipids and fats metabolism leading to obesity. Polyherbal formulation, Fattolin is currently being used in the treatment of obesity but not reported scientifically. Thus the present study investigates the anti-obesity effect of Fattolin in progesterone induced obesity model. Female Swiss albino mice were divided in four groups (n=6) and treated for 28 days, Group I received 2% gum acacia (10 ml/kg); Group II, III and IV received progesterone (10 mg/kg) subcutaneously and Group III and IV further received Fattolin orally at dose of 200 mg/kg and 400 mg/kg respectively. Increased food intake, body weight, liver weight, relative liver weight and, altered exploratory behaviour and biochemical estimations as well as histopathological changes were observed in non-treated progesterone control mice. Fattolin treatment (200 and 400 mg/kg) significantly decreased food intake, body weight and liver weight. A significant increase in number of ambulation and rearing and decrease in grooming was also observed. Moreover it significantlydecreased levels of blood glucose, triglycerides, total cholesterol, LDL, VLDL and liver enzymes; however more significant difference was observed with Fattolin 400 mg/kg treatment. Structural abnormality of hepatocytes like mild congestion and focal necrosis induced by progesterone administration was markedly improved with Fattolin treatment at both doses. Thus it can be concluded that, a polyherbal formulation, Fattolin possesses an anti-obesity activity.

Key words: Fattolin, Progesterone, Obesity, Total cholesterol, Body weight.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs